Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,870 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
Yamashita S, Takeshima H, Hata N, Uchida H, Shinojima N, Yokogami K, Nakano Y, Sakata K, Fudaba H, Enomoto T, Nakahara Y, Ujifuku K, Sugawara K, Iwaki T, Sangatsuda Y, Yoshimoto K, Hanaya R, Mukasa A, Suzuki K, Yamamoto J, Negoto T, Nakamura H, Momii Y, Fujiki M, Abe H, Masuoka J, Abe T, Matsuo T, Ishiuchi S; Kyushu Neuro-Oncology Study Group. Yamashita S, et al. Among authors: matsuo t. J Neurooncol. 2023 Apr;162(2):425-433. doi: 10.1007/s11060-023-04310-w. Epub 2023 Apr 13. J Neurooncol. 2023. PMID: 37052748
[Efficacy of antimicrobial prophylaxis in neurosurgical operations].
Morofuji Y, Ishizaka S, Takeshita T, Toyoda K, Ujifuku K, Hirose M, Izumo T, Tsunoda K, Hayashi K, Matsuo T, Kitagawa N, Suyama K, Nagata I. Morofuji Y, et al. Among authors: matsuo t. No Shinkei Geka. 2008 Sep;36(9):769-74. No Shinkei Geka. 2008. PMID: 18800630 Japanese.
Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model.
Toyoda K, Tanaka K, Nakagawa S, Thuy DH, Ujifuku K, Kamada K, Hayashi K, Matsuo T, Nagata I, Niwa M. Toyoda K, et al. Among authors: matsuo t. Cell Mol Neurobiol. 2013 May;33(4):489-501. doi: 10.1007/s10571-013-9913-z. Epub 2013 Feb 6. Cell Mol Neurobiol. 2013. PMID: 23385422 Free article.
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG). Wakabayashi T, et al. Among authors: matsuo t. J Neurooncol. 2018 Jul;138(3):627-636. doi: 10.1007/s11060-018-2831-7. Epub 2018 Mar 20. J Neurooncol. 2018. PMID: 29557060 Free PMC article. Clinical Trial.
2,870 results